「我不会当小白鼠」:在COVID-19背景下重新思考公共卫生传播与疫苗犹豫
本文为观点文章,讨论2021年初加拿大开始分发COVID-19疫苗时,公共卫生传播未能针对新疫苗引发的特定焦虑,而是沿用常规免疫的减少犹豫信息,且未充分解释疫苗推荐不断变化的原因;作者主张疫苗犹豫具有疫苗特异性,长期策略应解释技术新颖性与风险、说明指南变化原因并借助可信来源。
要点
- 2021年初加拿大开始分发COVID-19疫苗时公众关注度极高。
- 公共卫生信息未针对新疫苗特定焦虑,且未充分解释推荐变化。
- 作者认为疫苗犹豫具有疫苗特异性,长期策略应借助社区领袖等可信来源。
核心结论
- 作者认为公共卫生传播者必须承认疫苗犹豫具有疫苗特异性,新疾病和新疫苗会产生特定担忧。
- 作者提出长期策略应解释技术新颖性和风险的新颖性、充分说明疫苗推荐变化的原因,并借助社区领袖等可信来源。
- 作者指出随着COVID-19疫苗对某些近期变异株效果降低,疫苗信息需随现实变化调整以不丢失迄今接种运动的成果。
研究设计与样本
- 本文为观点文章,讨论2021年初加拿大开始分发COVID-19疫苗背景下的公共卫生传播与疫苗犹豫。
主要发现
- 2021年初加拿大开始分发COVID-19疫苗时,疫情空前范围和严重程度使公众知晓度和关注度非常高,加拿大人积极寻求信息。
- 尽管关于COVID-19和新疫苗的公共卫生传播持续进行,但这些信息未解决新疫苗引发的特定焦虑,即使接种指南发生变化。
- 关于COVID-19疫苗的公共卫生信息类似于针对常规免疫减少疫苗犹豫的信息,未充分应对COVID-19疫苗推荐内容的不断变化。
临床怎么用
- 作者建议传播者应承认疫苗犹豫具有疫苗特异性,新疾病和新疫苗会产生特定担忧。
- 作者建议长期策略应解释技术的新颖性和风险的新颖性,充分说明疫苗接种指南变化的原因,并借助社区领袖等可信来源。
- 作者建议随着COVID-19疫苗对某些近期变异株效果降低,疫苗信息需量身定制以随现实变化而演变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
At the beginning of 2021, when Canada started distribution of COVID-19 vaccines, the unprecedented scope and severity of the pandemic led to very high levels of public awareness and attention, with Canadians actively seeking information. We argue that while there was continuous public health communication about COVID-19 and the newly available vaccines, these messages did not address the specific anxieties elicited by the novel vaccines, even as vaccination guidelines changed. Instead, public health messages about COVID-19 vaccines resembled those aimed at reducing vaccine hesitancy for routine immunization and did not sufficiently address the constant changes to COVID-19 vaccine recommendations. In a context of heightened public concern and significant public attention, it is crucial for communicators to acknowledge that hesitancy is vaccine-specific, and that novel diseases and new vaccines produce specific concerns. Long-term strategies should address the novelty of the technology and of the risk, thoroughly explain the reasons for shifting vaccination guidelines, and leverage trusted sources, such as community leaders. Further, as COVID-19 vaccines become less effective against some of the more recent variants of the virus, vaccine messaging needs to be tailored to evolve with shifting realities to not lose productive gains in the COVID-19 vaccination campaign to date.
引用
- Michelle Driedger S, Capurro G, Tustin J, et al. "I won't be a guinea pig": Rethinking public health communication and vaccine hesitancy in the context of COVID-19. Vaccine. 2022. PMID: 36460532. doi:10.1016/j.vaccine.2022.11.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。